Publications

5674 Results

Randomized trial of 5-Fluorouracil and Mitomycin C with or without Streptozotocin for advanced pancreatic cancer.

Authors
RM Bukowski;SP Balcerzak;RM O'Bryan;JD Bonnet;TT Chen
Journal / Conference
Cancer 52:1577-1582
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7738

Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, Doxorubicin, and Mitomycin for residual localized gastric adenocarcinoma: A Southwest Oncology Group pilot study.

Authors
CD Haas;CM Mansfield;LP Leichman;B Considine;RM Bukowski
Journal / Conference
Cancer Treat Rep 67:421-424
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7864

Phase II trial of m-AMSA in gallbladder and cholangiocarcinoma: A Southwest Oncology Group study.

Authors
RM Bukowski;LP Leichman;SE Rivkin
Journal / Conference
Eur J Cancer Clin Oncol 19:721-723
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7920

Phase II study of Chlorozotocin in islet cell carcinoma: A Southwest Oncology Group study.

Authors
RM Bukowski;JD McCracken;SP Balcerzak;CJ Fabian
Journal / Conference
Cancer Chemother Pharmacol 11:48-50
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7935

The SWOG large bowel adjuvant program. An update.

Authors
FJ Panettiere;TT Chen
Journal / Conference
ASCO #C-455
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7510

Adjuvant chemotherapy with 5-Fluorouracil, Adriamycin and Mitomycin (FAM) in gastric cancer - A SWOG study.

Authors
R Gagliano;JD McCracken;T Chen
Journal / Conference
ASCO #C-443
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7804

Southwest Oncology Group Phase II-III gastric cancer study: 5-Fluorouracil, Adriamycin, and Mitomycin-C + Vincristine (FAM vs V-FAM) compared to chlorozotocin (CZT), m-AMSA, and Dihydroxyanthracenedione (DHAD) with unimpressive differences.

Authors
C Haas;N Oishi;B McDonald;C Coltman;R O'Bryan
Journal / Conference
ASCO #C-478
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7841

Evaluation of 5-FU vs. a Phase II drug in metastatic adenocarcinoma of the large bowel: Southwest Oncology Group (SWOG) study 7940.

Authors
L Leichman;C Fabian;R O'Bryan;JT Guy;W Fletcher;R Shildt;JD McCracken;T Chen
Journal / Conference
ASCO #C-469
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7940/45

AZQ in the treatment of colon cancer - A Southwest Oncology Group study.

Authors
R Shildt;J Bonnet;W Fletcher
Journal / Conference
ASCO #C-496
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-7940/45

Phase II trial of 5FU, Adriamycin, Cyclophosphamide, and Streptozotocin (FAC-S) in metastatic carcinoid (for the Southwest Oncology Group).

Authors
RM Bukowski;R Stephens;N Oishi;R Petersen;T Chen
Journal / Conference
ASCO #C-510
Year
1983
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8017